Preclinical Evaluation of 67Cu-labeled Intact and Fragmented Anti-Colon Carcinoma Monoclonal Antibody MAb

Cancer Research

Volumn 53, Issue 23, 1993, Pages 5727-5733

  Maecke, Helmut R ^b   Alberto, Roger ^a   Blaeuenstein, Peter ^a   Novak Hofer, Use ^a   Schubiger, P August ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; BENZOIC ACID DERIVATIVE; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; COPPER; COPPER 67; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IODINE 131; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOMA; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG LABELING; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; COLON TUMOR; IMMUNOLOGY; METABOLISM; METHODOLOGY; RADIOIMMUNOTHERAPY; TISSUE DISTRIBUTION; XENOGRAFT;

ANIMAL; ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; COPPER RADIOISOTOPES; FEMALE; HUMAN; IMMUNOGLOBULINS, FAB; IODINE RADIOISOTOPES; MICE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0027331360     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Scheinberg, D. A. Lovett, D. Divgi, C. R. Graham, M. C. Berman, E. Pentlow, K. Feirt, N. Finn, R. D. Clarkson, B. D. Gee, T. S. Larson, S. M. Oettgen, H. F. and Old, L. J. A Phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J. Clin. Oncol. 9: 478-490, 1991.
2. DeNardo, G. L. DeNardo, S. J. O'Grady, L. F. Mills, S. L. Lewis, J. P. and Macey, D. J. Radiation treatment of B cell malignancies with immunoconjugates. In: J. M. Vaeth (ed.), Frontiers of Radiation Therapy and Oncology: The Present and Future Role of Monoclonal Antibodies in the Management of Cancer, Vol. 24, pp. 194-201. Basel: S. Karger AG, 1990.
3. Stewart, W. S. Hird, V. Snook, D. Sullivan, M. Hooker, G. Courtenay-Luck, N. et al. Intraperitoneal radioimmunotherapy for ovarian cancer: pharmacokinetics, toxicity, and efficacy of 1-131 labeled monoclonal antibodies. Int. J. Radiat. Oncol. Biol. Phys. 16: 405-413, 1989.
4. Smith, A. Waibel, R. and Stahel, R. A. Selective immunotherapy of small cell cancer xenografts using 131I-labelled SWA11 antibody. Br. J. Cancer, 64: 263-266, 1991.
5. Beaumier, P. L. Venkatesan, P. Vanderheyden, J. L. Burgua, W. D. Kunz, L. L. Fritzberg, A. R. Abrams, P. G. and Morgan, A. C. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice. Cancer Res. 51: 676-681, 1991.
6. Novak-Hofer, I. Amstutz, H. P. Haldemann, A. Blaser, K. Morgenthaler, J. J. Blaeuenstein, P. and Schubiger, P. A. Radioimmunolocalization of neuroblastoma xenografts with chimeric antibody chCE7. J. Nucl. Med. 33: 231-236, 1992.
7. Humm, J. L. Dosimetric aspects of radiolabeled antibodies for tumor therapy. J. Nucl. Med. 27: 1490-1497, 1986.
8. Volkert, W. A. Goeckeler, W. F. Ehrhardt, G. J. and Ketring, A. R. Therapeutic radionuclides: production and decay property considerations. J. Nucl. Med. 32: 174-185, 1991.
9. Deshpande, S. V. DeNardo, S. J. Meares, C. F. McCall, M. J. Adams, G. P. Moi, M. K. and DeNardo, G. L. Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice. J. Nucl. Med. 29: 217-225, 1988.
10. DeNardo, G. DeNardo, S. J. Kukis, D. Diril, H. Suey, C. and Meares, C.F. Strategies for the enhancement of radioimmunotherapy. Nucl. Med. Biol. 18: 633-640, 1991.
11. Smith-Jones, P. M. Fridrich, R. Kaden, T. A. Novak-Hofer, I. Siebold, K. Tschudin, D. and Maecke, H. R. Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(l,4,8,ll-tetraazacyclotetradec-l-yl)methyl]benzoic acid. Bioconjugate Chem. 2: 415-421, 1991.
12. Studer, M. and Kaden, T. A. One-step synthesis of mono-N-substituted azamacrocycles with a carboxylic group in the side-chain, and their complexes with Cu2+ and Ni2+ Helv. Chim. Acta, 69: 2081-2086, 1986.
13. Buchegger, F. Haskell, C. M. Schreyer, M. Scazziga, B. R. Randin, S. Carrel, S. and Mach, J.P. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigens for localization of human colon carcinoma grafted into nude mice. J. Exp. Med, 158: 413-427, 1983.
14. Buchegger, F. Pelegrin, A. Delaloye, B. Bischof-Delaloye, A, and Mach, J. P. Iodine-131-labeled MAb F(ab’)2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. J. Nucl. Med, 31: 1035-1044, 1990.
15. Blumenthal, R. D. Sharkey, R. M. Kashi, R. and Goldenberg, D. M. Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model. Int. J. Cancer, 44: 292-300, 1989.
16. Milenic, D. E. Esteban, J. M. and Colcher, D. Comparison of methods for the generation of immunoreactive fragments of a monoclonal antibody (B72.3) reactive with human carcinomas. J. Immunol. Methods, 120: 71-83, 1989.
17. Wilbur, D. S. Hadley, S. W. Hylarides, M. D. Abrams, P. G. Beaumier, P. A. Morgan, A. C. Reno, J. M. and Fritzberg, A R. Development of a stable radioiodinating agent to label monoclonal antibodies for radiotherapy of cancer. J. Nucl. Med. 30: 216-226, 1989.
18. Lindmo, T. Boven, E, Cuttitta, F. Fedorko, J, and Bunn, P. A. Determination of the immunoreactive fraction of monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72: 77-89, 1984.
19. Mach, J. P. Buchegger, F. Forni, M, Ritschard, J. Berche, C, Lumbroso, J. D. Schreyer, M. Girardet, C, Accola, R. S. and Carrel, S. Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning tomoscintigraphy. Immunol. Today, 2: 239-249, 1981.
20. Delaloye, B. Bischof-Delaloye, A, Buchegger, F. von Fliedner, V. Grob, J.-P. Volant, J. C. Pellavel, J. and Mach, J.P. Detection of colorectel carcinoma by emission computerized tomography after injection of 125I-labeled Fab or F(ab’)2 fragments from four monoclonal anti-carcinoembryonic antigen antibodies. J. Clin. Invest. 77: 301-311, 1986.
21. Humm, J. L. Chin, L. M. and Macklis, R. M. F(ab’)2 fragments versus intact antibody-an isodose comparison. J. Nucl. Med, 31: 1045-1047, 1991.
22. Kojima, S. Suzuki, N, Shimura, N. Kubodera, A. Kubota, K. Yamaguchi, T, Takahashi, T. and Oyamada, H. Comparative study of intact A7 MoAb and F(ab’)2 fragment for radioimmunoimaging of human colon cancer in nude mice. Nucl. Med. Biol, 20: 243-248, 1993.
23. Brown, B. Comeau, R. D. Jones, P. L. Liberatore, F. A. Neacy, W. P. Sands, H. and Gallagher, B. M. Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In. Cancer Res, 47: 1149-1154, 1987.
24. Motta-Hennessy, C, Sharkey, R. M. and Goldenberg, D. M. Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. J. Nucl. Med. 31: 1510-1519, 1990.
25. Yemul, S. Leon, J. A. Pozniakoff, T. Esser, P. D. and Estabrook, A. Radioimmunoimaging of human breast carcinoma xenografts in nude mouse model with 111Inlabeled new monoclonal antibody EBA-1 and F(ab’)2 fragments. Nucl. Med. Biol, 20: 325-335, 1993.
26. Schott, M. E. Milenic, D. E. Yokota, T. Whitlow, M, Wood, J. F. Fordyce, W A, Cheng, R. C. and Schlom, J. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. Cancer Res, 52: 6413-6417, 1992.
27. Anderson, C. J. Connett, J. M. Schwarz, S. W. Rocque, P. A. Guo, L. W. Philpott, G. W. Zinn, K. R. Meares, C. F. and Welch, M. J. Copper-64-labeled antibodies for PET imaging. J. Nucl. Med, 33: 1685-1691, 1992.
28. Maack, T. Johnson, V, Kua, S. T. Figueiredo, J. and Sigulem, D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int. 16: 251-270, 1979.
29. Press, O. W. DeSantes, K, Anderson, S. K. and Geissler, F. Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores. Cancer Res, 50: 1243-1250, 1990.
30. van Dongen, G. Gerretsen, M, Visser, G. Brakenhoff, R, van Walsum, M. and Snow, G. Curative treatment of head and neck cancer xenografts using monoclonal antibody E48 IgG labeled with 186Re via the MAG3 chelate. Antibody Immunoconjugates and Radiopharmaceuticals, 6, Abstract 70, p. 84. Presented at the Eighth International Conference on Monoclonal Antibody Immunoconjugates for Cancer, San Diego, 1993.
31. Deshpande, S. V. DeNardo, S. J. Meares, C. F. McCall, M. J. Adams, G. P. and DeNardo, G. L. Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver. Nucl. Med. Biol, 16: 587-597, 1989.